Evolution Wealth Advisors, LLC Adaptive Biotechnologies Corp Transaction History

Evolution Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$32.22 - $44.59 $9,182 - $12,708	-285 Closed	0 $0
Q1 2021 Apr 20, 2021	BUY	$37.26 - $67.74 $2,086 - $3,793	56 Added 24.45%	285 $11,000
Q4 2020 Feb 02, 2021	BUY	$45.01 - $65.47 $1,575 - $2,291	35 Added 18.04%	229 $14,000
Q3 2020 Oct 15, 2020	BUY	$35.79 - $48.81 $6,943 - $9,469	194 New	194 $9,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $819M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.